Research statistics
Cerebrolysin research: publications and trials
At a glance
Publications, all years
591
Since 1973
Publications in 2026 so far
18
Through November 15, 2026
Human clinical research
37.5%
214 of 570 classified
Registered clinical trials
40
ClinicalTrials.gov
Randomized controlled trials
68
Publications reporting an RCT in people
Systematic reviews and meta-analyses
25
Preclinical studies
43.3%
225 animal · 19 in vitro · 3 computational
Records that only mention it
50
Not counted above
Status in the library: Research only. Groups: Cognitive and neurological peptides. 21 publications are not yet classified by study type.
What to keep in mind
- Some completed trials have neither posted results nor a linked results publication.
Publications by year
Cerebrolysin publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1973 | 0 | 0 | 0 | 1 | 1 |
| 1974 | 0 | 0 | 0 | 1 | 1 |
| 1975 | 1 | 2 | 0 | 2 | 5 |
| 1976 | 2 | 1 | 0 | 0 | 3 |
| 1977 | 0 | 0 | 0 | 1 | 1 |
| 1980 | 0 | 1 | 0 | 1 | 2 |
| 1981 | 0 | 1 | 0 | 1 | 2 |
| 1982 | 0 | 0 | 0 | 1 | 1 |
| 1983 | 0 | 0 | 0 | 1 | 1 |
| 1985 | 0 | 2 | 0 | 0 | 2 |
| 1989 | 0 | 0 | 0 | 1 | 1 |
| 1990 | 3 | 0 | 0 | 0 | 3 |
| 1991 | 2 | 2 | 0 | 0 | 4 |
| 1992 | 0 | 2 | 0 | 0 | 2 |
| 1993 | 0 | 1 | 0 | 1 | 2 |
| 1994 | 2 | 2 | 0 | 1 | 5 |
| 1995 | 2 | 3 | 0 | 0 | 5 |
| 1996 | 1 | 12 | 0 | 1 | 14 |
| 1997 | 4 | 3 | 0 | 1 | 8 |
| 1998 | 5 | 13 | 1 | 0 | 19 |
| 1999 | 2 | 9 | 1 | 1 | 13 |
| 2000 | 7 | 10 | 2 | 0 | 19 |
| 2001 | 3 | 6 | 1 | 1 | 11 |
| 2002 | 5 | 4 | 2 | 2 | 13 |
| 2003 | 2 | 5 | 0 | 0 | 7 |
| 2004 | 5 | 2 | 0 | 0 | 7 |
| 2005 | 5 | 4 | 0 | 1 | 10 |
| 2006 | 6 | 6 | 0 | 1 | 13 |
| 2007 | 4 | 4 | 1 | 0 | 9 |
| 2008 | 6 | 4 | 0 | 1 | 11 |
| 2009 | 5 | 2 | 2 | 0 | 9 |
| 2010 | 9 | 6 | 2 | 2 | 19 |
| 2011 | 8 | 7 | 2 | 2 | 19 |
| 2012 | 5 | 5 | 8 | 0 | 18 |
| 2013 | 5 | 9 | 3 | 1 | 18 |
| 2014 | 7 | 8 | 2 | 0 | 17 |
| 2015 | 8 | 9 | 3 | 1 | 21 |
| 2016 | 9 | 10 | 2 | 2 | 23 |
| 2017 | 9 | 8 | 7 | 3 | 27 |
| 2018 | 5 | 9 | 2 | 0 | 16 |
| 2019 | 9 | 15 | 5 | 1 | 30 |
| 2020 | 8 | 9 | 7 | 0 | 24 |
| 2021 | 7 | 10 | 7 | 0 | 24 |
| 2022 | 11 | 3 | 3 | 0 | 17 |
| 2023 | 11 | 16 | 9 | 1 | 37 |
| 2024 | 8 | 8 | 8 | 3 | 27 |
| 2025 | 14 | 11 | 5 | 2 | 32 |
| 2026 (to date) | 9 | 3 | 4 | 2 | 18 |
Study types
| Animal study | 225 |
|---|---|
| Other clinical trial | 82 |
| Randomized controlled trial | 68 |
| Review | 64 |
| Observational human study | 37 |
| Case report | 27 |
| Meta-analysis | 21 |
| Not yet classified | 21 |
| In vitro study | 19 |
| Editorial, letter or other | 17 |
| Systematic review | 4 |
| Computational study | 3 |
| Guideline or consensus | 3 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Neurological and mental health | 550 |
|---|---|
| Cardiovascular | 208 |
| Cognitive health | 192 |
| Tissue repair | 104 |
| Immune system | 23 |
| Metabolic health | 21 |
| Musculoskeletal | 17 |
| Longevity and aging | 16 |
| Endocrinology | 12 |
| Reproductive and sexual health | 7 |
| Gastrointestinal | 6 |
| Antimicrobial and infectious disease | 5 |
Registered clinical trials
8 of 17 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 18 · Unknown status: 10 · Not yet recruiting: 3 · Recruiting: 3 · Terminated: 3 · Active, not recruiting: 1 · Enrolling by invitation: 1 · Withdrawn: 1
Early phase 1: 1 · Phase not applicable: 9 · Phase 1: 1 · Phase 1 / Phase 2: 2 · Phase 2: 7 · Phase 2 / Phase 3: 2 · Phase 3: 5 · Phase 4: 13
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Cerebrolysin and Risk of Hemorrhagic Transformation: A Pooled Analysis of Recent Studies.
Journal of clinical neurology (Seoul, Korea) · March 1, 2026 · Meta-analysis · cited 0 times · open access
PMID 41775380 · DOI 10.3988/jcn.2025.0547 · Reviews and meta-analyses
- Efficacy and Safety of Cerebrolysin as an Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.
Brain and behavior · March 1, 2026 · Meta-analysis · cited 2 times · open access
PMID 41880098 · DOI 10.1002/brb3.71252 · Reviews and meta-analyses
- [The effect of Cerebrolysin on the development of skills in patients after acute cerebrovascular accidents].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2026 · Meta-analysis · cited 0 times
PMID 41782528 · DOI 10.17116/jnevro202612602132 · Reviews and meta-analyses
- [Cerebrolysin as an early add-on to reperfusion therapy: heterogeneous treatment effect analysis in ischemic stroke patients with varying risk of hemorrhagic transformation].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2024 · Meta-analysis · cited 5 times · open access
PMID 38512096 · DOI 10.17116/jnevro202412403255 · Reviews and meta-analyses
- The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.
Journal of Alzheimer's disease : JAD · January 1, 2022 · Meta-analysis · cited 53 times
PMID 34924395 · DOI 10.3233/jad-215423 · Reviews and meta-analyses
- European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischaemic stroke.
European journal of neurology · June 21, 2021 · Meta-analysis · cited 64 times · open access
PMID 34152062 · DOI 10.1111/ene.14936 · Reviews and meta-analyses
- The efficacy and safety of animal-derived nootropics in cognitive disorders: Systematic review and meta-analysis.
Cerebral circulation - cognition and behavior · April 16, 2021 · Meta-analysis · cited 12 times · open access
PMID 36324709 · DOI 10.1016/j.cccb.2021.100012 · Reviews and meta-analyses
- Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · February 23, 2021 · Meta-analysis · cited 22 times · open access
PMID 33620612 · DOI 10.1007/s10072-020-04974-6 · Reviews and meta-analyses
- Cerebrolysin for acute ischaemic stroke.
The Cochrane database of systematic reviews · July 14, 2020 · Meta-analysis · cited 18 times
PMID 32662068 · DOI 10.1002/14651858.cd007026.pub6 · Reviews and meta-analyses
- Cerebrolysin for vascular dementia.
The Cochrane database of systematic reviews · November 11, 2019 · Meta-analysis · cited 39 times
PMID 31710397 · DOI 10.1002/14651858.cd008900.pub3 · Reviews and meta-analyses
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke.
Journal of neuroscience research · November 1, 2010 · Animal study · cited 194 times · open access
PMID 20857512 · DOI 10.1002/jnr.22495 · Animal studies
- Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Stroke · November 12, 2015 · Randomized controlled trial · cited 160 times · open access
PMID 26564102 · DOI 10.1161/strokeaha.115.009416 · Human clinical research
- Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke.
Stroke · May 21, 2013 · Animal study · cited 147 times
PMID 23696546 · DOI 10.1161/strokeaha.111.000831 · Animal studies
- Non-cholinergic strategies for treating and preventing Alzheimer's disease.
CNS drugs · January 1, 2002 · Review · cited 142 times
PMID 12421115 · DOI 10.2165/00023210-200216120-00003 · Reviews and meta-analyses
- The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.
Drugs of today (Barcelona, Spain : 1998) · April 1, 2012 · Review · cited 135 times
PMID 22514792 · DOI 10.1358/dot.2012.48(suppl.a).1739716 · Reviews and meta-analyses
Latest publications
- Longitudinal Serum and Cerebrospinal Fluid S100B Concentrations After Aneurysmal Subarachnoid Hemorrhage: An Exploratory Comparison of Historical Cohorts With and Without Cerebrolysin Exposure.
Journal of clinical medicine · November 9, 2026 · Not yet classified · cited 0 times · open access
PMID 43030876 · DOI 10.3390/jcm15218734 · Not yet classified
- Very Early Short-Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report.
Case reports in neurological medicine · August 28, 2026 · Case report · cited 0 times · open access
PMID 42666484 · DOI 10.1155/crnm/9962315 · Human clinical research
- Adjunctive Cerebrolysin therapy following mechanical thrombectomy for tandem right internal carotid artery and middle cerebral artery occlusion with residual post-procedural perfusion deficit: a case report.
Journal of medicine and life · August 1, 2026 · Case report · cited 0 times · open access
PMID 42891269 · DOI 10.25122/jml-2026-0102 · Human clinical research
- Research-Evidence-Practice Gaps in Post-stroke Neuro-recovery Pharmacological Therapies in Asia.
Cerebrovascular diseases extra · July 29, 2026 · Observational human study · cited 0 times · open access
PMID 42525569 · DOI 10.1159/000553635 · Human clinical research
- Improvement of aphasia deficits following traumatic intracranial hemorrhage: a case report.
Journal of medicine and life · July 1, 2026 · Case report · cited 0 times · open access
PMID 42751610 · DOI 10.25122/jml-2026-0072 · Human clinical research
- Adjunctive Cerebrolysin therapy following mechanical thrombectomy for acute basilar artery occlusion: a case report.
Journal of medicine and life · June 1, 2026 · Case report · cited 0 times · open access
PMID 42602665 · DOI 10.25122/jml-2026-0081 · Human clinical research
- Cerebrolysin as an adjunct to speech-language therapy in post-stroke Wernicke's aphasia: a case report.
Journal of medicine and life · June 1, 2026 · Case report · cited 0 times · open access
PMID 42602663 · DOI 10.25122/jml-2026-0057 · Human clinical research
- Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability.
Cells · May 19, 2026 · In vitro study · cited 0 times · open access
PMID 42193943 · DOI 10.3390/cells15100934 · In vitro studies
- Biochemical and Pharmacological Studies on Kynurenic Acid Metabolism in the <i>Helix pomatia</i>-Snail Model of Learning and Memory.
Biomolecules · April 18, 2026 · Animal study · cited 0 times · open access
PMID 42072724 · DOI 10.3390/biom16040603 · Animal studies
- Cerebrolysin and Risk of Hemorrhagic Transformation: A Pooled Analysis of Recent Studies.
Journal of clinical neurology (Seoul, Korea) · March 1, 2026 · Meta-analysis · cited 0 times · open access
PMID 41775380 · DOI 10.3988/jcn.2025.0547 · Reviews and meta-analyses
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Cerebrolysin; FPE 1070
((TITLE_ABS:"Cerebrolysin" OR CHEM:"Cerebrolysin") OR (TITLE_ABS:"FPE 1070" OR CHEM:"FPE 1070" OR TITLE_ABS:"FPE1070" OR CHEM:"FPE1070")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Cerebrolysin research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/cerebrolysin